Table I.
Factors influencing dysmenorrhea relief as determined by p-VAS.
| Variables | No relief (n=8) | Partial relief (n=13) | Near-complete relief (n=28) | P-value |
|---|---|---|---|---|
| p-VAS | 9.38±0.74 | 4.46±0.97 | 0.46±0.69 | <0.001 |
| Age (years) | 41.4±6.8 | 40.6±4.7 | 40.3±5.1 | 0.884 |
| Body Mass Index (kg/m2) | 22.3±3.5 | 22.8±2.5 | 23.1±3.3 | 0.831 |
| Menorrhagia | 0.369 | |||
| Yes, % (n) | 12.5% (2) | 43.8% (7) | 43.8% (7) | |
| No, % (n) | 18.2% (6) | 18.2% (6) | 63.6% (21) | |
| Gravidity | 1.8±1.0 | 1.8±1.0 | 2.5±1.0 | 0.055 |
| History of cesarean delivery | 0.558 | |||
| Yes, % (n) | 23.1% (3) | 7.7% (1) | 69.2% (9) | |
| No, % (n) | 13.9% (5) | 33.3% (12) | 52.8% (19) | |
| Preoperative serum cancer antigen 125 level (U/ml) | 84.9±79.2 | 91.6±47.9 | 74.1±54.6 | 0.647 |
| Pathological uterine size (cm3) | 127.0±58.2 | 145.9±68.3 | 145.5±93.1 | 0.845 |
| No of adenomyomas | 0.919 | |||
| Single, % (n) | 18.2% (4) | 22.7% (5) | 59.1% (13) | |
| Multiple, % (n) | 14.8% (4) | 29.6% (8) | 55.6% (15) | |
| Coexisting endometriosis | 0.203 | |||
| Yes, % (n) | 8.7% (2) | 26.1% (6) | 65.2% (15) | |
| No, % (n) | 23.1% (6) | 26.9% (7) | 50.0% (13) | |
| Accompanying uterine leiomyoma | 0.344 | |||
| Yes, % (n) | 14.2% (2) | 42.9% (6) | 42.9% (6) | |
| No, % (n) | 17.1% (6) | 20.0% (7) | 62.9% (22) | |
| Laparoscopic presacral neurectomy | 0.796 | |||
| Yes, % (n) | 12.5% (1) | 37.5% (3) | 50.0% (4) | |
| No, % (n) | 17.1% (7) | 24.4% (10) | 58.5% (24) | |
| Postoperative gonadotropin-releasing hormone agonist therapy | 0.566 | |||
| Yes, % (n) | 19.2% (5) | 26.9% (7) | 53.9% (14) | |
| No, % (n) | 13.0% (3) | 26.1% (6) | 60.9% (14) | |
| Postoperative levonorgestrel-releasing intrauterine system treatment | 0.503 | |||
| Yes, % (n) | 25% (2) | 0% (0) | 75% (6) | |
| No, % (n) | 14.6% (6) | 31.7% (13) | 53.7% (22) |
Data are presented as mean ± standard deviation. p-VAS, postoperative visual analogue scale.